{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:31:38Z","timestamp":1785047498090,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.det.2016.11.001","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T02:21:10Z","timestamp":1489717270000},"page":"107-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Medical Treatment of Vitiligo"],"prefix":"10.1016","volume":"35","author":[{"given":"James J.","family":"Nordlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2016.11.001_bib1","series-title":"The pigmentary system: physiology and pathophysiology","author":"Nordlund","year":"2006"},{"key":"10.1016\/j.det.2016.11.001_bib2","unstructured":"Greenwood M. Varfor Grater Puman? Tryckt i Belgien: Bra Bocker; 1984."},{"key":"10.1016\/j.det.2016.11.001_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archderm.1974.01630060081033","article-title":"Leyden. Vitiligo in ancient Indian medicine","volume":"109","author":"Berger","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2016.11.001_bib4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/archderm.1966.01600240110023","article-title":"White spots in biblical times","volume":"93","author":"Goldman","year":"1966","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2016.11.001_bib5","series-title":"Vitiligo: a monograph on the basic and clinical science","first-page":"13","article-title":"History and cultural aspects of vitiligo","author":"Kopera","year":"2000"},{"key":"10.1016\/j.det.2016.11.001_bib6","series-title":"Sixteenth century physician and his methods","first-page":"226","article-title":"Mercurialis on disease of the skin","author":"Mercurialis","year":"1572"},{"key":"10.1016\/j.det.2016.11.001_bib7","series-title":"Vitiligo and other hypomelanoses of hair and skin","first-page":"652","article-title":"Vitiligo","author":"Ortonne","year":"1982"},{"key":"10.1016\/j.det.2016.11.001_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1098\/rstl.1695.0142","article-title":"An account of a negro-boy that is dappel'd in several places of his body with white spots","volume":"19","author":"Byrd","year":"1695","journal-title":"Phil Trans"},{"issue":"1269","key":"10.1016\/j.det.2016.11.001_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bmj.1.1269.834","article-title":"On leucoderm, vitiligo, ven kuttam (Tamil) or cabbare (Singhalese), and several new methods of treatment","volume":"1","author":"Brito","year":"1885","journal-title":"Br Med J"},{"key":"10.1016\/j.det.2016.11.001_bib10","series-title":"The pigmentary system: physiology and pathophysiology","first-page":"91","article-title":"Extracutaneous melanocytes","author":"Boissy","year":"2006"},{"issue":"6","key":"10.1016\/j.det.2016.11.001_bib11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0161-6420(79)35413-6","article-title":"Ocular abnormalities occurring with vitiligo","volume":"86","author":"Albert","year":"1979","journal-title":"Ophthalmology"},{"key":"10.1016\/j.det.2016.11.001_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bjo.67.3.153","article-title":"Vitiligo and disorders of the retinal pigment epithelium","volume":"67","author":"Albert","year":"1983","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.det.2016.11.001_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0190-9622(81)70051-3","article-title":"The prevalence of vitiligo and poliosis in patients with uveitis","volume":"4","author":"Nordlund","year":"1981","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/bjd.14361","article-title":"Quality of life impact of childhood skin conditions measured using the children's dermatology life quality index (CDLQI): a meta-analysis","volume":"174","author":"Olsen","year":"2016","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.001_bib15","first-page":"493","article-title":"Response to cosmetic disfigurement: patients with vitiligo","volume":"39","author":"Porter","year":"1987","journal-title":"Cutis"},{"key":"10.1016\/j.det.2016.11.001_bib16","series-title":"The pigmentary system: physiology and pathophysiology","first-page":"5","article-title":"The history of the science of pigmentation","author":"Klaus","year":"2008"},{"key":"10.1016\/j.det.2016.11.001_bib17","first-page":"469","article-title":"The psoralens: an historical perspective","volume":"20","author":"Benedetto","year":"1977","journal-title":"Cutis"},{"key":"10.1016\/j.det.2016.11.001_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/jid.1959.40","article-title":"Historical aspects of methoxsalen and other furocoumarins","volume":"31","author":"Fitzpatrick","year":"1959","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2016.11.001_bib19","series-title":"Diseases of the skin","first-page":"585","article-title":"Pigment anomalies","author":"Ormsby","year":"1927"},{"key":"10.1016\/j.det.2016.11.001_bib20","first-page":"612","article-title":"Ultra-violet therapy in cases of leucoderma","volume":"80","author":"Menon","year":"1945","journal-title":"Ind Med Gaz"},{"key":"10.1016\/j.det.2016.11.001_bib21","first-page":"651","article-title":"A\u00a0preliminary clinical report on the treatment of leucodermia with Ammi majus Linn","volume":"31","author":"El-Mofty","year":"1948","journal-title":"J\u00a0Egypt Med Assoc"},{"issue":"1","key":"10.1016\/j.det.2016.11.001_bib22","first-page":"1","article-title":"Further study on treatment of leucodermia with Ammi mafus Linn","volume":"35","author":"El-Mofty","year":"1952","journal-title":"J\u00a0Egypt Med Assoc"},{"issue":"12","key":"10.1016\/j.det.2016.11.001_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2133.1952.tb15880.x","article-title":"Observations on the use of Ammi majus Linn. In vitiligo","volume":"64","author":"El-Mofty","year":"1952","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.001_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1523-1747.ep12480997","article-title":"Role of hair follicles in the repigmentation of vitiligo","volume":"97","author":"Cui","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/jid.1953.36","article-title":"Clinical and experimental studies with 8-methoxypsoralen in vitiligo","volume":"20","author":"Lerner","year":"1953","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2016.11.001_bib26","first-page":"165","article-title":"Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo","volume":"66","author":"Pathak","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"issue":"1\u20132","key":"10.1016\/j.det.2016.11.001_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/1011-1344(92)85080-E","article-title":"The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD","volume":"14","author":"Pathak","year":"1992","journal-title":"J\u00a0Photochem Photobiol B"},{"key":"10.1016\/j.det.2016.11.001_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.001_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2006.01413.x","article-title":"Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo","volume":"20","author":"Parsad","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2 Pt 1","key":"10.1016\/j.det.2016.11.001_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.001_bib31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1067\/mjd.2001.114752","article-title":"Narrow-band ultraviolet B is a useful and well-tolerated treatment for\u00a0vitiligo","volume":"44","author":"Scherschun","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.11.001_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1346-8138.2006.00079.x","article-title":"Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo","volume":"33","author":"Arca","year":"2006","journal-title":"J\u00a0Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.001_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0781.2005.00139.x","article-title":"No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo","volume":"21","author":"Ada","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"10.1016\/j.det.2016.11.001_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0781.2004.00114.x","article-title":"Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo","volume":"20","author":"Kullavanijaya","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.det.2016.11.001_bib35","series-title":"Vitiligo: current knowledge and nutritional therapy","author":"Montes","year":"2006"},{"issue":"6","key":"10.1016\/j.det.2016.11.001_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2230.1989.tb02602.x","article-title":"Cutaneous and ocular side-effects of PUVA photochemotherapy: a 10-year follow-up study","volume":"14","author":"Abdullah","year":"1989","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555572305306","article-title":"PUVA treatment of vitiligo: a retrospective study of 59 patients","volume":"72","author":"Wildfang","year":"1992","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.det.2016.11.001_bib38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3349\/ymj.1996.37.6.392","article-title":"Ten-year experience of phototherapy in Yonsei Medical Center","volume":"37","author":"Park","year":"1996","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.det.2016.11.001_bib39","series-title":"Psoralens: past, present and future of photochemoprotection and other biological activities","first-page":"103","article-title":"PUVA 5-MOP\u00a0+ phenylalanine in the treatment of vitiligo. Study of 125 patients: preliminary results","author":"Beretti","year":"1989"},{"issue":"2","key":"10.1016\/j.det.2016.11.001_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF00414110","article-title":"Phenylalanine and UVA light for the treatment of vitiligo","volume":"277","author":"Cormane","year":"1985","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib41","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1470.1989.tb00921.x","article-title":"Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo","volume":"6","author":"Schulpis","year":"1989","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"10.1016\/j.det.2016.11.001_bib42","first-page":"324","article-title":"Vitiligo treated with mepacrine","volume":"65","author":"Pegum","year":"1953","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.001_bib43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2340\/0001555554453455","article-title":"Vitiligo treated with chloroquine: a preliminary report","volume":"35","author":"Christiansen","year":"1955","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib44","first-page":"333","article-title":"Khellin, a naturally occurring furochromone, used for the photochemotherapy of skin diseases: mechanism of action","volume":"43","author":"Vedaldi","year":"1988","journal-title":"Farmaco Sci"},{"issue":"2","key":"10.1016\/j.det.2016.11.001_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000249932","article-title":"An approach to the treatment of vitiligo by khellin","volume":"165","author":"Abdel-Fattah","year":"1982","journal-title":"Dermatologica"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2003.05577.x","article-title":"KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in\u00a0vitro","volume":"149","author":"Carlie","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2016.11.001_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00128071-200405020-00004","article-title":"Levamisole in dermatology: a review","volume":"5","author":"Scheinfeld","year":"2004","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"10.1016\/j.det.2016.11.001_bib48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-4362.1994.tb02903.x","article-title":"Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease","volume":"33","author":"Pasricha","year":"1994","journal-title":"Int J Dermatol"},{"issue":"32","key":"10.1016\/j.det.2016.11.001_bib49","first-page":"1451","article-title":"Clofazimine (lamprene) in the treatment of vitiligo","volume":"47","author":"Bor","year":"1973","journal-title":"S\u00a0Afr Med J"},{"issue":"2","key":"10.1016\/j.det.2016.11.001_bib50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaad.2006.08.017","article-title":"High-potency steroid use in children with vitiligo: a retrospective study","volume":"56","author":"Kwinter","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 12","key":"10.1016\/j.det.2016.11.001_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2133.1976.tb02268.x","article-title":"The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies","volume":"94","author":"Bleehen","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2016.11.001_bib52","series-title":"Vitiligo: a monograph on the basic and clinical science","first-page":"173","article-title":"Steroid treatment for vitiligo","author":"Hann","year":"2000"},{"issue":"1","key":"10.1016\/j.det.2016.11.001_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archderm.143.1.119","article-title":"Effect of tacrolimus on vitiligo in absence of UV radiation exposure","volume":"143","author":"Sardana","year":"2007","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.det.2016.11.001_bib54","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1610-0387.2006.06124.x","article-title":"Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study","volume":"4","author":"Dawid","year":"2006","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"5","key":"10.1016\/j.det.2016.11.001_bib55","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.001_bib56","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archderm.142.2.252","article-title":"Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure","volume":"142","author":"Ostovari","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2016.11.001_bib57","series-title":"The pigmentary system: physiology and pathophysiology","first-page":"394","article-title":"Human pigmentation: its regulation by ultraviolet light and by endocrine, paracrine and autocrine factors","author":"Abdel-Malek","year":"2006"},{"issue":"2","key":"10.1016\/j.det.2016.11.001_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-3083.2002.00407.x","article-title":"Treatment of vitiligo by topical calcipotriol","volume":"16","author":"Chiaverini","year":"2002","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2016.11.001_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1468-3083.2003.00795.x","article-title":"Is the combination of calcipotriol and PUVA effective in vitiligo?","volume":"17","author":"Baysal","year":"2003","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2016.11.001_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000249389","article-title":"Repigmentation of vitiligo macules treated topically with Efudex cream","volume":"171","author":"Szekeres","year":"1985","journal-title":"Dermatologica"},{"issue":"9","key":"10.1016\/j.det.2016.11.001_bib61","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archderm.1983.01650330014006","article-title":"Topically administered fluorouracil in vitiligo","volume":"119","author":"Tsuji","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2016.11.001_bib62","series-title":"Vitiligo: monograph on basic and clinical science","first-page":"182","article-title":"Pseudocatalase in the treatment of vitiligo","author":"Schallreuter","year":"2000"},{"issue":"3","key":"10.1016\/j.det.2016.11.001_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000246690","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients [see comments]","volume":"190","author":"Schallreuter","year":"1995","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2016.11.001_bib64","first-page":"77","article-title":"The effect of pseudocatalase\/superoxide dismutase in the treatment of vitiligo: a pilot study","volume":"1","author":"Naini","year":"2012","journal-title":"J\u00a0Res Pharm Pract"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib65","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2133.2009.09292.x","article-title":"Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture","volume":"161","author":"Gawkrodger","year":"2009","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib66","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2133.2009.09252.x","article-title":"A\u00a0randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo","volume":"161","author":"Bakis-Petsoglou","year":"2009","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.det.2016.11.001_bib67","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2230.2002.01142.x","article-title":"Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study","volume":"27","author":"Patel","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.11.001_bib68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-4362.1992.tb03559.x","article-title":"Non-psoralen treatment of vitiligo. Part I. Cosmetics, systemic coloring agents, and corticosteroids","volume":"31","author":"Goldstein","year":"1992","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.001_bib69","first-page":"577","article-title":"Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases","volume":"12","author":"Boehncke","year":"2002","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.11.001_bib70","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516301280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516301280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:44:33Z","timestamp":1692726273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863516301280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0733863516301280"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2016.11.001","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Medical Treatment of Vitiligo","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}